United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,019 | 56,533 | 82,812 | 82,586 | 86,378 |
| Marketable Securities | 41,638 | 38,690 | 7,000 | 200 | N/A |
| Receivables | 20,198 | 16,604 | 14,678 | 15,808 | 11,068 |
| Inventories | 10,276 | 9,812 | 9,101 | 8,014 | 7,239 |
| Other current assets | 645 | 1,635 | 1,880 | 654 | 1,788 |
| TOTAL | $146,891 | $126,631 | $119,306 | $110,492 | $107,959 |
| Non-Current Assets | |||||
| PPE Net | 20,392 | 20,409 | 17,711 | 17,799 | 17,337 |
| Investments And Advances | 75,249 | 72,837 | 65,180 | 63,798 | 53,961 |
| Intangibles | 13,072 | 13,192 | 13,312 | 13,432 | 13,552 |
| Other Non-Current Assets | 1,569 | 1,155 | 1,416 | 1,637 | 2,301 |
| TOTAL | $110,282 | $107,593 | $97,619 | $96,666 | $87,151 |
| Total Assets | $257,173 | $234,224 | $216,925 | $207,158 | $195,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 586 | 795 | 10 | 16 | 18 |
| Accounts payable and accrued liabilities | 4,063 | 3,881 | 3,057 | 6,127 | 2,661 |
| Accrued Expenses | 12,433 | 11,007 | 8,858 | 7,689 | 10,443 |
| Other current liabilities | N/A | N/A | N/A | N/A | 58 |
| TOTAL | $17,123 | $15,755 | $11,925 | $13,864 | $14,187 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9 | 14 | 10 | 10 | 13 |
| Other Non-Current Liabilities | 1,684 | 1,657 | 1,680 | 1,648 | 1,571 |
| TOTAL | $1,693 | $1,671 | $1,690 | $1,658 | $1,584 |
| Total Liabilities | $18,816 | $17,426 | $13,615 | $15,522 | $15,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,229 | 45,633 | 45,253 | 44,986 | 44,590 |
| Common Shares | 236 | 233 | 231 | 229 | 228 |
| Retained earnings | -144,735 | -160,498 | -172,680 | -180,341 | -187,231 |
| Other shareholders' equity | 2,136 | 1,952 | 4,167 | 2,803 | 45 |
| TOTAL | $238,357 | $216,798 | $203,310 | $191,636 | $179,339 |
| Total Liabilities And Equity | $257,173 | $234,224 | $216,925 | $207,158 | $195,110 |